The downgrade is based on a number of factors, including THS’ marked decline in operating performance in fiscal year 2015. Offsetting THS’ challenges are its leading market position and steady liquidity levels.
The outlook is negative, reflecting Moody’s Investors Service’s expectation that THS will keep experiencing financial pressure in the coming months.
More articles on healthcare finance:
Profit margins at St. Louis-area hospitals rise as charity care levels fall
Moody’s assigns ‘Aa1/VMIG 1′ to IHC Health Services’ bonds
Are rising deductibles driving a political shift in healthcare?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
